about
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
Read More
14.99
-0.11
(-0.73%)
75,706
XNAS Volume
XNAS 08 Aug, 2025 5:30 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
Amarin Corp - ADR Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..